Back
IWLD
iShares Core MSCI World Ex Australia Esg ETF
🇦🇺 ASX
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
🌳 ENVIRONMENTAL
📈 HIGH PRICE GROWTH
🌏 GLOBAL
👑 Overview
📈 Performance
📙 Holdings
💰 Distributions
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
+ 15.69%
Annual Growth
5 years average annual capital growth
💰
1.33%
Annual distribution yield
Based on the most recent distribution
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
208
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
The IWLD ETF seeks to track the performance of the MSCI World ex-Australia Custom ESG Leaders Index before considering any fees, expenses, and taxes.
📈 Performance
Price History
+155.29%
1M
1Y
All Time
Graph
Table
How could long term investing grow your wealth?*
Based on an initial investment of
$
and recurring investments every
for
$
Your wealth could grow to...
$93,536.07
after 5 years
$294,200.73
after 10 years
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →📙 Top Holdings
Show more
AUD CASH
1.16%
Updated as of 21 August 2025
Industry Exposure
🤖 Information
32%
🏦 Financials
16%
🏭 Industrials
11%
🛍️ Consumer
10%
🩺 Health
9%
📙 Other
8%
📞 Communication
6%
🧱 Materials
3%
🏡 Real Estate
2%
⚡️ Utilities
2%
🔋 Energy
1%
Country Exposure
🇺🇸 United States
75%
🇯🇵 Japan
6%
🇬🇧 United Kingdom of Great Britain and Northern Ireland
3%
🇨🇦 Canada
3%
🇨🇭 Switzerland
3%
🇫🇷 France
2%
🇳🇱 Netherlands
2%
🇩🇰 Denmark
1%
🇩🇪 Germany
1%
🇸🇪 Sweden
1%
🇮🇹 Italy
1%
💰 Distributions
Payouts
💰 Annual Distribution Yield*
1.33%
💰 Annual Distribution Earnings Per $1,000 invested**
$13.29
💰 Most Recent Distribution Franked Percentage Estimate
0.00%
💰 Average Distribution Franked Percentage Estimate
0.00 %
💰 Distribution reinvestment
* Based on the most recent distribution
** Calculated by multiplying the most recent distribution yield by $1,000
Estimate your distribution
If you held
$
of IWLD, your last distribution payment(s) would have been:
$ 81.97
on Fri Jul 11 2025
$ 49.83
on Fri Jan 17 2025
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Distribution History
1Y
5Y
10Y
Graph
Table
Year
Yearly Distribution Earnings Per Share
Franking Estimate
2025
$0.83
0.00%
2024
$0.71
0.00%
2023
$1.13
0.00%
2022
$0.37
0.00%
2021
$6.41
0.00%
2020
$0.88
0.00%
2019
$0.89
0.00%
2018
$0.78
0.00%
2017
$0.45
0.00%
2016
$0.22
0.00%
💵 Costs
💼
0.09%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🍃 Environmental, Social and Governance scores ℹ️
🌳
Environmental Score
99
A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution
⚖️
Governance Score
75
An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.
🤓 Advanced information
Technical Info
💰 Price*
$65.10
💰 Price To Earnings Ratio
24.91
💰 Price To Book Ratio
4.54
💰 Leveraged
No
💰 Inverse
No
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in IWLD
208
📊 Total Capital Earnings
$2.3M
🔃 Average investment frequency
39 weeks
💵 Average investment amount
$4,068
⏰ Last time a customer invested in IWLD
3 mins
IWLD investor breakdown
💵 Income of investors
More than 200k
8%
150k - 200k
10%
100k - 150k
16%
50k - 100k
25%
Less than 50k
40%
👶 Age of investors
18 - 25
10%
26 - 34
32%
35 - 90
58%
🙋 Legal gender of investors
Female
45%
Male
55%
Pearlers who invest in IWLD also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 21916.72m in AUM and 303 holdings. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
9.16%
📊 Share price
$111.21 AUD
🇦🇺 AUSTRALIA
⛳️ DIVERSIFIED
💸 FINANCIALS
📈 HIGH PRICE GROWTH
🧱 MATERIALS
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
21.68%
📊 Share price
$66.03 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
16.87%
📊 Share price
$147.72 AUD
🌏 GLOBAL
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 8203.28m in AUM and 199 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
🙌 Performance (5Yr p.a)
9.86%
📊 Share price
$149.56 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
7.10%
📊 Share price
$72.73 AUD
⛳️ DIVERSIFIED
🌏 GLOBAL
Want more shares? Try these...
Invex Therapeutics Ltd. is a biopharmaceutical company, which engages in the research and development of treatment for neurological conditions resulting from raised intracranial pressure. The company is headquartered in Perth, Western Australia. The company went IPO on 2019-07-05. The firm is focused on the repurposing of an already-approved drug, Exenatide, for the efficacious treatment of neurological conditions derived from or involving raised intracranial pressure (ICP). In addition, the Company has generated early-stage data on the use of Exenatide in the treatment of glaucoma, through the lowering of intraocular pressure in the eye. The principal activity of the Company is the development of Exenatide, including generating new pre-clinical data in Alzheimer’s Disease (AD) under a collaboration with Tessara Therapeutics. The firm has trademarked its repurposed Exenatide as Presendin. The firm is focused on managing the close out of the Phase III Idiopathic Intracranial Hypertension (IIH) EVOLVE clinical trial and explore new potential applications for Exenatide in TBI and other neurological disorders with raised ICP, consistent with its patents.
🙌 Performance (5Yr p.a)
-17.98%
📊 Share price
$0.10 AUD
📦 LOGISTICS
🕊️
Social Score
80
An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.